Selected article for: "lung disease and severe lung disease"

Author: Zhichao Feng; Jennifer Li; Shanhu Yao; Qizhi Yu; Wenming Zhou; Xiaowen Mao; Huiling Li; Wendi Kang; Xin Ouyang; Ji Mei; Qiuhua Zeng; Jincai Liu; Xiaoqian Ma; Pengfei Rong; Wei Wang
Title: The Use of Adjuvant Therapy in Preventing Progression to Severe Pneumonia in Patients with Coronavirus Disease 2019: A Multicenter Data Analysis
  • Document date: 2020_4_10
  • ID: k65501xp_50
    Snippet: is the (which was not peer-reviewed) The copyright holder for this preprint . https://doi.org/10.1101/2020.04.08.20057539 doi: medRxiv preprint benefits in clinical settings. But importantly, our results show the potential protective effects of ACEI or ARB therapy to limiting progression to severe lung disease in hypertensive patients......
    Document: is the (which was not peer-reviewed) The copyright holder for this preprint . https://doi.org/10.1101/2020.04.08.20057539 doi: medRxiv preprint benefits in clinical settings. But importantly, our results show the potential protective effects of ACEI or ARB therapy to limiting progression to severe lung disease in hypertensive patients.

    Search related documents:
    Co phrase search for related documents
    • ARB therapy and progression limit: 1
    • ARB therapy and protective effect: 1, 2, 3, 4, 5
    • clinical setting and lung disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
    • clinical setting and protective effect: 1, 2, 3, 4
    • hypertensive patient and lung disease: 1
    • lung disease and progression limit: 1
    • lung disease and protective effect: 1, 2, 3, 4, 5, 6, 7, 8, 9